Brief: Century Therapeutics Reports Q3 2021 Financial Results
10/11/2021 12:31
Nov 10 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $0.48
* Q3 EARNINGS PER SHARE VIEW $-0.40 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3gsLQN
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview